MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ejh.70295

Медицинская библиотека · European journal of haematology · 2026

Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R-CHOP: A Lymphoma Registry Study.

Yao Yao, Sungur Serif, Wellard Cameron, Chung Eliza, Morgan Susan, Lee Denise, Chong Geoffrey, Cheah Chan Y, Hawkes Eliza A, Wood Erica M, Hamad Nada, Johnston Anna M, Armytage Tasman

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

BMI may capture clinically relevant differences in host reserve and treatment vulnerability in diffuse large B-cell lymphoma (DLBCL). We evaluated the association between BMI and survival outcomes.

METHODS

Adults with DLBCL receiving first-line R-CHOP chemoimmunotherapy from 2016 to 2026 were identified from the Lymphoma and Related Diseases Registry. BMI was analysed as underweight, normal weight/overweight, obese Class I and obese Class II/III. Overall survival (OS) and progression-free survival (PFS) were analysed using Kaplan-Meier and Cox models adjusted for International Prognostic Index (IPI) components, sex and cardiac history.

RESULTS

Among 1600 patients, 43 (2.7%) were underweight, 303 (18.9%) had obese Class I BMI and 198 (12.4%) had obese Class II/III BMI. At median follow-up of 35.4 months, 342 deaths occurred, including 15 in underweight patients. OS differed by BMI category (log-rank p = 0.017), whereas PFS did not (log-rank p = 0.082). In complete-case multivariable analysis, underweight BMI remained associated with inferior OS (adjusted HR, 1.89; 95% CI, 1.06-3.37). Exploratory analyses did not identify chemotherapy exposure, including upfront dose reduction, or measured malnutrition/systemic illness markers that explained this association.

CONCLUSIONS

Underweight BMI identified patients at increased risk of inferior survival, even after adjustment for IPI-based prognostic factors. Obese BMI categories were not associated with inferior survival.

Для цитирования: Yao Yao, Sungur Serif, Wellard Cameron, Chung Eliza, Morgan Susan, Lee Denise, Chong Geoffrey, Cheah Chan Y, Hawkes Eliza A, Wood Erica M, Hamad Nada, Johnston Anna M, Armytage Tasman. Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R-CHOP: A Lymphoma Registry Study.. European journal of haematology. 2026. DOI: 10.1111/ejh.70295.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.